Theranostics · 2021 · 22 citations · 0 references
Life SciencesMolecular BiologyOncologyCancer GeneticsGene ExpressionMolecular OncologyCancer TranscriptomicsMetabolic ReprogrammingMetabolic Reprogramming In CancerSignal Transduction In CancerTherapeutic Genome EditingTherapeutic ResistanceArgininosuccinate Synthetase DeficiencyCancer Gene EditingCrispr-cas9 KnockoutGenome-wide Crispr ScreeningGenome-wide Knockout ScreeningMolecular Drug ResistanceResistance ClonesTherapeutic Resistance Mechanisms
We uncovered TREM1/CCL2 activation, in addition to restored ASS1 expression, as a key pathway involved in full ADI-resistance in breast and prostate cancer models.